Cargando…
AAV9-mediated central nervous system–targeted gene delivery via cisterna magna route in mice
Current barriers to the use of adeno-associated virus serotype 9 (AAV9) in clinical trials for treating neurological disorders are its high expression in many off-target tissues such as liver and heart, and lack of cell specificity within the central nervous system (CNS) when using ubiquitous promot...
Autores principales: | Lukashchuk, Vera, Lewis, Katherine E, Coldicott, Ian, Grierson, Andrew J, Azzouz, Mimoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756767/ https://www.ncbi.nlm.nih.gov/pubmed/26942208 http://dx.doi.org/10.1038/mtm.2015.55 |
Ejemplares similares
-
Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna
por: Hinderer, Christian, et al.
Publicado: (2014) -
Puncture of the Cisterna Magna
por: Stewart, Donald
Publicado: (1929) -
A Single Cisterna Magna Injection of AAV Leads to Binaural Transduction in Mice
por: Blanc, Fabian, et al.
Publicado: (2022) -
Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
por: Chatterjee, Diptaman, et al.
Publicado: (2021) -
Manic Episode Associated with Mega Cisterna Magna
por: Turan, Tayfun, et al.
Publicado: (2010)